❖ We invest primarily in the U.S. public equity market due to its robustness, maturity and access to credible data. We have been able to achieve amazing results to our investors in this market and have deep knowledge

❖ We hold medium to long term investment positions; while “carefully” taking “short” positions to exploit market opportunities.

❖ Our bias is to invest significantly in disruptive technologies within the biomedical, pharmaceuticals, future energy and future transportation industries.

❖ Our key objective that influences our research, our investment decisions and our hedging schemes is to achieve investment profits for our clients that are consistently higher than the investment returns achieved by the best world-class hedge funds. Therefore our fund is classified as a Capital Appreciation hedge fund.